Investigational New Drugs,volume 29,issue 4  (08-2014)

Period of time： 2014年4期

Publisher： Springer Publishing Company

Founded in： 1983

Total resources： 32

ISSN： 0167-6997

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 29,issue 4

Menu

A novel structural derivative of natural alkaloid ellipticine, MDPSQ, induces necrosis in leukemic cells

By Shahabuddin M. in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 523-533

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Potent anti-tumor activity of a macrocycle-quinoxalinone class pan-Cdk inhibitor in vitro and in vivo

By Hirai Hiroshi in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 534-543

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells

By Wilmes Anja,Rawson Pisana,Peng Lifeng,McLauchlan Danyl,Northcote Peter,Jordan T.,Miller John in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 544-553

Springer Publishing Company

Abstract Access to resources Recommend Favorite

AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo

By Torres Mylin,Raju Uma,Molkentine David,Riesterer Oliver,Milas Luka,Ang K. in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 554-561

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism

By Hoyt Mirth in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 562-573

Springer Publishing Company

Abstract Access to resources Recommend Favorite

LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin

By Gao Jian-Jun in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 574-582

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A natural compound, methyl angolensate, induces mitochondrial pathway of apoptosis in Daudi cells

By Chiruvella Kishore in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 583-592

Springer Publishing Company

Abstract Access to resources Recommend Favorite

The anti-proliferative side effects of AEE788, a tyrosine kinase inhibitor blocking both EGF- and VEGF-receptor, are liver-size-dependent after partial hepatectomy in rats

By Deng Meihong in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 593-606

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Anticancer activity and mode of action of titanocene C

By Olszewski Ulrike,Claffey James,Hogan Megan,Tacke Matthias,Zeillinger Robert,Bednarski Patrick,Hamilton Gerhard in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 607-614

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Peloruside A inhibits microtubule dynamics in a breast cancer cell line MCF7

By Chan Ariane,Andreae Peter,Northcote Peter,Miller John in (2011)

Investigational New Drugs,volume 29,issue 4 , Vol. 29, Iss. 4, 2011-08 , pp. 615-626

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Previous 1 2 3 Next Display item(s) per page Total 23 item(s)